» Articles » PMID: 28824377

MPTP-Induced Dopamine Depletion in Basolateral Amygdala Decrease of D2R Activation Suppresses GABA Receptors Expression and LTD Induction Leading to Anxiety-Like Behaviors

Overview
Specialty Molecular Biology
Date 2017 Aug 22
PMID 28824377
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Anxiety disorders commonly occur in Parkinson's disease. Using field potential recording and patch-clamp recording, we evaluated influence of MPTP-reduced dopaminergic afferent in basolateral amygdala (BLA), a main region for affective regulation, on excitatory-inhibitory circuits and synaptic plasticity. Field excitatory post-synaptic potential (fEPSP) slopes at external capsule-BLA synapses were increased in MPTP-mice with decreases in paired-pulse facilitation and long-term potentiation amplitude, which were corrected by bath-application of D2R agonist quinpirole or cannabinoid type 1 receptors agonist WIN55,212-2, but not D1R agonist SKF38393. Compared to single waveform fEPSP in control mice, a multi-spike waveform fEPSP was observed in MPTP-mice with prolongation of duration and an increase in paired-pulse inhibition, which were recovered by BLA-injection of quinpirole for 2 days rather than bath-application. Density of GABA-evoked current () in BLA principal neurons and GABAR-α2 subunit expression were reduced in MPTP-mice, which were recovered by administration of quinpirole. Decline of PKC phosphorylation in BLA of MPTP-mice was corrected by bath-application of quinpirole, but not SKF38393. In MPTP-mice, BLA-injection of quinpirole or PKC activator PMA could recover GABAR expression, which was sensitive to PKC inhibitor GF109203X. The impairment of long-term depression (LTD) in MPTP-mice was rescued by bath-application of GABAR agonist muscimol or BLA-injection of quinpirole and PMA. Finally, BLA-injection of muscimol, quinpirole or PMA relieved anxiety-like behaviors in MPTP-mice. The results indicate that the MPTP-induced dopamine depletion in BLA principal neurons through reducing D2R-mediated PKC phosphorylation suppresses GABAR expression and activity, which impairs GABAR-mediated inhibition and LTD induction leading to anxiety-like behaviors.

Citing Articles

Multi-omics analysis reveals the neuroprotective effect of extract against Parkinson's disease in mouse.

Sohi K, Sueun L, Byeong Cheol M, Jun Ho S, Sung-Ho K, Changjong M J Tradit Chin Med. 2024; 44(6):1111-1117.

PMID: 39617696 PMC: 11589551. DOI: 10.19852/j.cnki.jtcm.2024.06.002.


Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies.

Thi Lai T, Gericke B, Feja M, Conoscenti M, Zelikowsky M, Richter F NPJ Parkinsons Dis. 2023; 9(1):97.

PMID: 37349373 PMC: 10287685. DOI: 10.1038/s41531-023-00547-4.


Amygdalo-nigral circuit mediates stress-induced vulnerability to the parkinsonian toxin MPTP.

Cai H, Zhang P, Li T, Li M, Zhang L, Cui C CNS Neurosci Ther. 2023; 29(7):1940-1952.

PMID: 36914579 PMC: 10324352. DOI: 10.1111/cns.14151.


Repeated inhibition of sigma-1 receptor suppresses GABA receptor expression and long-term depression in the nucleus accumbens leading to depressive-like behaviors.

Qin Y, Xu W, Li K, Luo Q, Chen X, Wang Y Front Mol Neurosci. 2022; 15:959224.

PMID: 36245919 PMC: 9563353. DOI: 10.3389/fnmol.2022.959224.


αCaMKII in the lateral amygdala mediates PTSD-Like behaviors and NMDAR-Dependent LTD.

An S, Wang J, Zhang X, Duan Y, Xu Y, Lv J Neurobiol Stress. 2021; 15:100359.

PMID: 34258335 PMC: 8252123. DOI: 10.1016/j.ynstr.2021.100359.


References
1.
Rosenkranz J, Grace A . Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning. Nature. 2002; 417(6886):282-7. DOI: 10.1038/417282a. View

2.
von Bohlen Und Halbach O, Schober A, Hertel R, Unsicker K . MPTP treatment impairs tyrosine hydroxylase immunopositive fibers not only in the striatum, but also in the amygdala. Neurodegener Dis. 2006; 2(1):44-8. DOI: 10.1159/000086430. View

3.
Mirante O, Brandalise F, Bohacek J, Mansuy I . Distinct molecular components for thalamic- and cortical-dependent plasticity in the lateral amygdala. Front Mol Neurosci. 2014; 7:62. PMC: 4080466. DOI: 10.3389/fnmol.2014.00062. View

4.
Rodriguez-Oroz M, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E . Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 2009; 8(12):1128-39. DOI: 10.1016/S1474-4422(09)70293-5. View

5.
Isoardi N, Martijena I, Carrer H, Molina V . Increased fear learning coincides with neuronal dysinhibition and facilitated LTP in the basolateral amygdala following benzodiazepine withdrawal in rats. Neuropsychopharmacology. 2004; 29(10):1852-64. DOI: 10.1038/sj.npp.1300478. View